INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186,333 | -10.4% | 479,006 | +2.8% | 0.00% | – |
| Q2 2023 | $207,959 | -88.9% | 465,753 | -79.5% | 0.00% | – |
| Q1 2023 | $1,866,170 | -49.0% | 2,275,816 | -3.0% | 0.00% | -100.0% |
| Q4 2022 | $3,659,858 | -2.7% | 2,346,063 | +7.6% | 0.00% | 0.0% |
| Q3 2022 | $3,760,000 | +9.1% | 2,179,617 | +9.4% | 0.00% | 0.0% |
| Q2 2022 | $3,446,000 | -49.3% | 1,992,194 | +5.3% | 0.00% | 0.0% |
| Q1 2022 | $6,792,000 | -30.8% | 1,891,847 | -3.8% | 0.00% | -50.0% |
| Q4 2021 | $9,810,000 | -32.0% | 1,965,928 | -2.5% | 0.00% | -33.3% |
| Q3 2021 | $14,437,000 | -24.7% | 2,016,370 | -2.5% | 0.00% | 0.0% |
| Q2 2021 | $19,176,000 | -2.4% | 2,068,697 | -2.3% | 0.00% | -25.0% |
| Q1 2021 | $19,648,000 | +16.6% | 2,117,295 | +11.2% | 0.00% | +33.3% |
| Q4 2020 | $16,848,000 | -24.2% | 1,903,696 | -0.7% | 0.00% | -40.0% |
| Q3 2020 | $22,228,000 | -56.2% | 1,916,221 | +1.9% | 0.01% | -58.3% |
| Q2 2020 | $50,705,000 | +460.7% | 1,881,407 | +54.8% | 0.01% | +300.0% |
| Q1 2020 | $9,043,000 | +161.7% | 1,215,486 | +16.1% | 0.00% | +200.0% |
| Q4 2019 | $3,455,000 | +46.2% | 1,046,791 | -9.3% | 0.00% | 0.0% |
| Q3 2019 | $2,364,000 | -22.5% | 1,153,708 | +11.1% | 0.00% | 0.0% |
| Q2 2019 | $3,052,000 | -24.2% | 1,038,256 | -3.8% | 0.00% | 0.0% |
| Q1 2019 | $4,025,000 | -4.0% | 1,079,202 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $4,194,000 | -27.3% | 1,048,508 | +1.0% | 0.00% | 0.0% |
| Q3 2018 | $5,770,000 | +43.3% | 1,037,740 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $4,026,000 | -13.9% | 1,026,797 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $4,678,000 | +11.4% | 993,242 | -2.4% | 0.00% | 0.0% |
| Q4 2017 | $4,201,000 | -36.4% | 1,017,283 | -2.4% | 0.00% | -50.0% |
| Q3 2017 | $6,610,000 | -5.9% | 1,042,653 | +16.3% | 0.00% | 0.0% |
| Q2 2017 | $7,028,000 | +21.7% | 896,472 | +2.8% | 0.00% | 0.0% |
| Q1 2017 | $5,773,000 | +0.7% | 872,106 | +5.5% | 0.00% | 0.0% |
| Q4 2016 | $5,734,000 | -24.2% | 826,267 | +1.8% | 0.00% | 0.0% |
| Q3 2016 | $7,565,000 | +0.5% | 811,679 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $7,528,000 | +4.0% | 814,736 | -1.9% | 0.00% | 0.0% |
| Q1 2016 | $7,235,000 | +30.8% | 830,750 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $5,530,000 | +20.3% | 823,073 | +3.5% | 0.00% | 0.0% |
| Q3 2015 | $4,597,000 | -28.1% | 795,197 | +1.5% | 0.00% | 0.0% |
| Q2 2015 | $6,390,000 | +15.8% | 783,194 | +15.8% | 0.00% | 0.0% |
| Q1 2015 | $5,518,000 | -8.2% | 676,259 | +3.2% | 0.00% | 0.0% |
| Q4 2014 | $6,014,000 | -8.1% | 655,104 | -1.4% | 0.00% | 0.0% |
| Q3 2014 | $6,547,000 | +256.2% | 664,729 | +291.0% | 0.00% | +100.0% |
| Q2 2014 | $1,838,000 | – | 169,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |